2Gorell JM, Johnsona CC, Rybicki BA, et al. Occupational exposure to manganese, copper,lead,iron, mercury and zinc and the risk of Parkinson' s disease.. Neurotoxicology, 1999,20:239-247.
4Logroscino G, Marder K, Graziano J, et al. Altered systemic iron metabolism in Parkinson's disease Neurology, 1997,49 : 714-717.
5Torsdottir G, Kistinsson J, Sveinbjomsdottir S,et al. Copper. Ceruloplasmin superoxide dismutase an iron parameters in Parkinson' s disease. Pharmacol Toxicol, 1999,85:239-243.
二级参考文献5
1Zatta P, Lucchini R, van Rensburg SJ, et al. The role of metals in neurodegenerative processes: aluminum, manganese,and zinc[J]. Brain Res Bull, 2003,62:15-28.
2Gwiazda RH, Lee D, Sheridan J, et al. Low cumulative manganese exposure affects striatal GABA but not dopamine[J].Neurotoxicology, 2002,23:69-76.
3Purdey M. Ecosystems supporting clusters of sporadic TSE demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant cofactors Cu, Se,Fe, Zn. Does a foreign cation substitution at prion's Cu domain initiate TSE? [J]. Med Hypotheses, 2000,54 : 278-306.
4Crossgrove JS, Allen DA, Bukaveckas BL, et al. Manganese distribution across the blood-brain barrier. L evidence for carrier-mediated influx of manganese citrate as well as manganese and manganese transferring[ J]. Neurotoxicology, 2003,24:3-13.
5Yokel RA, Crossgrove .IS, Bukaveckas BL. Manganese distribution across the blood-brain barrier. Ⅱ. manganese efflux from the brain does not appear to be carrier mediated[J]. Neurotoxicology, 2003,24 : 15-22.
